Biomark Diagnostics Market Cap

Biomark Diagnostics has a market cap or net worth of $21.57 million as of June 20, 2025. Its market cap has increased by 68.60% in one year.

Market Cap

21.57M

Enterprise Value

22.65M

Revenue

107.75K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.23

Market Cap Chart

Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 35.57M to 21.57M, a decrease of -39.37%. That is a compound annual growth rate of -4.62%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	21.57M	109.81%
Dec 30, 2024	10.28M	-24.05%
Dec 29, 2023	13.53M	27.76%
Dec 30, 2022	10.59M	-28.16%
Dec 30, 2021	14.74M	116.26%
Dec 30, 2020	6.82M	-49.96%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	792.66M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	435.36M
Glass House Brands	391.34M
CytoDyn	387.16M

Market Cap Rankings